These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3414239)

  • 1. [Evoked potentials and the prediction of the efficacy of psychopharmaceutical agents].
    Kolomaznik M; Komzák F; Haloupková L; Seidl I; Hronek J
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):108-10. PubMed ID: 3414239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia, psychoticism, neuroleptics, and auditory evoked potentials.
    Schlör KH; Moises HW; Haas S; Rieger H
    Pharmacopsychiatry; 1985 Sep; 18(5):293-6. PubMed ID: 4048264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of evoked potentials in psychiatry. III. Evoked potentials and prediction of the effectiveness of psychopharmaceuticals].
    Chaloupková L; Komzák F; Kolomazník M; Seidl J; Hronek J; Sefrna F
    Cesk Psychiatr; 1988 Aug; 84(4):217-22. PubMed ID: 3180280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the wave composition of evoked potentials during treatment of endogenous depression].
    Loginov VV; Magalif AIu; Leshchinskaia IP; Trubnikov VI; Nemtsov AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):431-5. PubMed ID: 3705856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory brain stem and cortical evoked potentials in schizophrenia.
    Pfefferbaum A; Horvath TB; Roth WT; Tinklenberg JR; Kopell BS
    Biol Psychiatry; 1980 Apr; 15(2):209-23. PubMed ID: 7417612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.
    Adler G; Markert U; Gattaz WF
    Pharmacopsychiatry; 1994 Mar; 27(2):68-9. PubMed ID: 7913236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of auditory function in comatose patients in therapy with potentially ototoxic substances using acoustically evoked brain stem potentials].
    Piek J; Lumenta CB; Bock WJ
    Anasth Intensivther Notfallmed; 1985 Feb; 20(1):1-5. PubMed ID: 3993873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
    Araki T; Kasai K; Rogers MA; Kato N; Iwanami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1083-90. PubMed ID: 16723179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study.
    Altamura AC; Buccio M; Colombo G; Terzi A; Cazzullo CL
    Encephale; 1986; 12(1):31-6. PubMed ID: 3698889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term gentamicin ototoxicity in the rat: research on retro-cochlear involvement by study of evoked auditory potentials of the brain stem].
    de Lavernhe-Lemaire MC; Garand G
    Arch Int Physiol Biochim; 1985 May; 93(1):7-18. PubMed ID: 2409945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early evoked auditory potentials in transient ischemic attacks of the posterior circle of Willis].
    Rossi L; Ubiali E; Rottoli MR; Merli R
    Riv Neurol; 1983; 53(2):106-15. PubMed ID: 6879057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Auditory evoked potentials of the brain stem in the study of tinnitus].
    García Bartual E; Armengot Carceller M; Marco Algarra J; Mencheta E; Pitarch I
    Acta Otorrinolaringol Esp; 1989; 40(4):285-9. PubMed ID: 2629937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives].
    Wegrzyn J; Wciórka J
    Psychiatr Pol; 2004; 38(3):395-408. PubMed ID: 15199650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.